Guillaume Cadiot

机构：Centre Hospitalier Universitaire de Reims, Université de Reims Champagne-Ardenne · ORCID：0000-0002-2726-8715

发表论文 404 篇 · 总被引 14507 次 · h-index 64

代表论文

• Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study (2021 · ˜The œLancet. Gastroenterology & hepatology · 被引 96)
• Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study (2023 · The Lancet Oncology · 被引 67)
• French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d’étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1 (2023 · Annales d Endocrinologie · 被引 33)
• Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors (2021 · Neuroendocrinology · 被引 27)
• Efficacy of treatments for VIPoma: A GTE multicentric series (2021 · Pancreatology · 被引 22)
• Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID (2023 · Journal of Crohn s and Colitis · 被引 21)